INS and obesity disorder: AhR overexpression exacerbates diet-induced hepatosteatosis by upregulating CD36 and increasing fatty acid uptake into liver14, 32, while protecting against obesity and diabetes by induction of FGF2112, a hepatokine with lipid-lowering and insulin-sensitizing effects28.